Skip to main content
Log in

Epimerization and Hydrolysis of Dalvastatin, a New Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

In aqueous solutions, dalvastatin (1) undergoes epimerization as well as hydrolysis. The transformation of the drug was studied as a function of pH at 25°C in aqueous solutions containing 20% acetonitrile. At all pH values, first-order plots for the conversion are biphasic, indicating rapid equilibration of 1 with its epimer (2) and slower hydrolysis of 1 to the corresponding β-hydroxy acid (3). Apparent first-order rate constants for the biexponential equation are given as a function of pH. The alkyl–oxygen cleavage of the lactone ring results in the epimerization of 1 to 2, whereas the acyl–oxygen cleavage results in the hydrolysis of 1 to 3. The epimerization is an SN1 reaction reaching an equilibrium of [l] eq/[2] eq = 1.27. The epimerization rate is increased with an increase in the water content of the solvent. The hydrolysis of 1 to 3 is acid and base catalyzed. The hydrolysis is reversible in acidic media and irreversible in neutral and basic media. At pH values greater than 9, the hydrolysis reaction proceeds more rapidly than the epimerization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. D. Amin, S. Gustafson, J. Weinacht, S. Cornell, K. Neuenschwander, B. Kosmider, A. Scotese, J. Regan, and M. Perrone. RG 12561, a novel, synthetic inhibitor of HMG CoA reductase and hypocholesterolemic agent that achieves high drug liver/plasma ratio. Arteriosclerosis 10:828a (1990).

    Google Scholar 

  2. D. Amin and K. Neuenschwander. Dalvastatin. Drugs Fut. 17:377–379 (1992).

    Google Scholar 

  3. S. M. Grundy. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N. Engl. J. Med. 319:24–33 (1988).

    Google Scholar 

  4. V. K. Khetarpal, L. S. Storbeck, D. Wells, and R. H. Meacham. Method for separation and determination of lactone and hydroxy acid forms of a new HMG CoA reductase inhibitor (RG 12561) in plasma. J. Chromatogr. 567:491–497 (1991).

    Google Scholar 

  5. A. A. Frost and R. G. Pearson. Kinetics and Mechanism, Wiley, New York, 1961, pp. 162–164.

    Google Scholar 

  6. E. S. Gould. Mechanism and Structure in Organic Chemistry, Holt, Rinehart and Winston, New York, 1962, p. 316.

    Google Scholar 

  7. E. R. Garrett and C. M. Won. Prediction of stability in pharmaceutical preparations. XVI. Kinetics of hydrolysis of canrenone and lactonization of canrenoic acid. J. Pharm. Sci. 60:1801–1809 (1971).

    Google Scholar 

  8. M. J. Kaufman. Rate and equilibrium constants for acid-catalyzed lactone hydrolysis of HMG-CoA reductase inhibitors. Int. J. Pharm. 66:97–106 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Won, C.M. Epimerization and Hydrolysis of Dalvastatin, a New Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor. Pharm Res 11, 165–170 (1994). https://doi.org/10.1023/A:1018978602141

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018978602141

Navigation